Compare RMBS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMBS | RVTY |
|---|---|---|
| Founded | 1990 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.8B |
| IPO Year | 1997 | N/A |
| Metric | RMBS | RVTY |
|---|---|---|
| Price | $101.26 | $95.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 15 |
| Target Price | $103.14 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 3.6M | 1.6M |
| Earning Date | 02-02-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | ★ 27.88 | N/A |
| EPS | ★ 2.11 | 2.07 |
| Revenue | $707,630,000.00 | ★ $2,856,051,000.00 |
| Revenue This Year | $17.66 | $6.06 |
| Revenue Next Year | $17.96 | $5.15 |
| P/E Ratio | $48.32 | ★ $46.68 |
| Revenue Growth | ★ 27.13 | 3.67 |
| 52 Week Low | $40.12 | $81.36 |
| 52 Week High | $135.75 | $120.39 |
| Indicator | RMBS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 36.96 |
| Support Level | $94.30 | $93.70 |
| Resistance Level | $112.66 | $106.55 |
| Average True Range (ATR) | 9.91 | 4.40 |
| MACD | -1.89 | -1.69 |
| Stochastic Oscillator | 27.98 | 10.61 |
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.